ClinConnect ClinConnect Logo
Search / Trial NCT04579835

Twin A Breech External Cephalic Version Intervention Trial (TWEXIT)

Launched by CHARITE UNIVERSITY, BERLIN, GERMANY · Oct 1, 2020

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

The Twin A Breech External Cephalic Version Intervention Trial (TWEXIT) is a study looking at a specific technique called external cephalic version (ECV) for women expecting twins where the first baby (Twin A) is in a breech position, meaning they are positioned feet or bottom down instead of head down. The goal of this trial is to see if this technique can help safely turn the baby into the head-down position before delivery, which may lead to a better outcome for both mother and babies.

To participate in this trial, women need to be over 18 years old and able to give their consent to join. Unfortunately, women under 18, those with certain pregnancy complications like placenta previa (where the placenta covers the cervix), or those with fetal abnormalities cannot take part in the study. For eligible participants, joining the trial means they will receive care and monitoring related to this technique, and they will be contributing valuable information that could help improve care for future pregnancies.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Presence of the written consent of the patients.
  • The patients must be over 18 years old .
  • No limit in the ability to consent.
  • Exclusion Criteria:
  • Age under 18
  • Limited ability to consent
  • Placenta previa
  • Fetal abnormalities

About Charite University, Berlin, Germany

Charité - Universitätsmedizin Berlin is a leading academic medical center in Germany, renowned for its commitment to excellence in research, education, and patient care. As one of Europe's largest university hospitals, Charité integrates cutting-edge clinical practices with innovative research initiatives, fostering interdisciplinary collaboration across various medical fields. The institution is dedicated to advancing healthcare through rigorous clinical trials, contributing to the development of new therapies and treatment protocols. With a strong emphasis on translational medicine, Charité aims to bridge the gap between scientific discovery and practical application, ultimately enhancing patient outcomes and public health.

Locations

Berlin Mitte, , Germany

Patients applied

0 patients applied

Trial Officials

Larry Hinkson, FRCOG

Principal Investigator

Charité University Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials